A Feasibility Study for Elective Cardioversion of Atrial Fibrillation at Home

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 7, 2024

Primary Completion Date

August 29, 2024

Study Completion Date

February 10, 2025

Conditions
Emergency Medical ServicesElectric Countershock
Interventions
PROCEDURE

Duble current electro cardioversion

Instead of the regular clinical treatment, in this study direct-current electrical cardioversion (DC-ECV) will be performed at the patient's home and will be carried out by well-trained and certified advanced practice providers (APP) on site, i.e. nurse practitioner or physician assistant, supported by an EMS ambulance team containing an ambulance nurse and ambulance driver, both trained advanced life-support (ALS) professionals.

Trial Locations (1)

5212VM

RAV Brabant MWN, 's-Hertogenbosch

All Listed Sponsors
collaborator

Jeroen Bosch Ziekenhuis

OTHER

lead

RAV Brabant MWN

OTHER

NCT06322836 - A Feasibility Study for Elective Cardioversion of Atrial Fibrillation at Home | Biotech Hunter | Biotech Hunter